Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-05-07T19:30:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-04-30T14:19:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T12:25:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial involving daratumumab and donor lymphocyte infusions for treating relapsed acute myeloid leukemia, while adding a new registry identifier and a revision number.
    Difference
    37%
    Check dated 2025-04-16T09:56:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T04:56:19.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.6%
    Check dated 2025-04-01T22:16:32.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.